AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glytac-M 80mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Polard Healthcare

Salt Composition

Gliclazide (80mg) + Metformin (500mg)

Overview Glytac-M 80mg/500mg Tablet

Diabetic patients using Metformin/Glibenclamide 80mg/500mg tablets should be aware that this dual-action medication manages type 2 diabetes in adults by regulating blood glucose. Administer this medication orally with food, consistently at the same time daily for optimal results. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your healthcare provider. Lifestyle modifications are integral to successful diabetes control. Common side effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation; and vomiting. Carrying readily available glucose sources (e.g., sugary snacks, juice) is essential for managing hypoglycemia. Alcohol consumption should be limited due to its potential to exacerbate low blood sugar. Other potential side effects are altered taste perception, nausea, diarrhea, abdominal discomfort, headaches, and upper respiratory infections. Weight gain may also occur. This medication is contraindicated for individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Pregnant or lactating women should seek medical advice before use. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to assess blood cell counts and liver function.

Uses of Glytac-M 80mg/500mg Tablet

Adult-onset diabetes

Major Benefits of Glytac-M 80mg/500mg Tablet:

Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glytac-M 80mg/500mg Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medicine with a meal.

Common Side effects of Glytac-M 80mg/500mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Glytac-M 80mg/500mg Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glytac-M 80mg/500mg tablet whole; do not fragment or pulverize it. Administer this medication with a meal.

How Glytac-M 80mg/500mg Tablet works:

Each Glytac-M 80mg/500mg tablet contains gliclazide and metformin, two medications used to manage blood sugar levels in individuals with diabetes.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glytac-M 80mg/500mg tablets with alcohol is not recommended due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glytac-M 80mg/500mg tablets during pregnancy poses a confirmed risk to the fetus. Nevertheless, a physician might, in exceptional life-threatening circumstances, deem its use justifiable if the potential advantages outweigh the inherent dangers. Physician consultation is essential.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Glytac-M 80mg/500mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glytac-M 80mg/500mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is recommended. Glytac-M 80mg/500mg tablets are contraindicated in individuals with severe kidney disease. Routine monitoring of renal function is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glytac-M 80mg/500mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiation should be at a low dose; the medication is contraindicated in severe cases.

What if you forget to take Glytac-M 80mg/500mg Tablet :

Should you forget a Glytac-M 80mg/500mg Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glytac-M 80mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glytac-M 80mg/500mg Tablet

Glytac-M 80mg/500mg tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Glytac-M 80mg/500mg tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infection. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Glytac-M 80mg/500mg Tablets can cause low blood sugar (hypoglycemia), characterized by nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and shakiness or anxiety. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice to treat low blood sugar.
Glytac-M 80mg/500mg Tablets can cause lactic acidosis, a serious medical emergency resulting from excess lactic acid in the blood (also known as MALA, or Metformin-associated lactic acidosis). This is a rare side effect, but it's crucial to avoid use in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glytac-M 80mg/500mg immediately and seek immediate medical attention.
Prolonged Glytac-M 80mg/500mg Tablet use can lead to vitamin B12 deficiency by impairing its stomach absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 intake is recommended annually by some researchers.
Glytac-M 80mg/500mg Tablets are contraindicated in patients with allergies to any ingredient or excipient. They should also be avoided in those with moderate to severe kidney disease or metabolic acidosis, including diabetic ketoacidosis.
Combining Glytac-M 80mg/500mg tablets with alcohol is unsafe. This combination can worsen low blood sugar and raise the risk of lactic acidosis.
Glytac-M 80mg/500mg tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. Glytac-M is not suitable for type 1 diabetes.
Glytac-M 80mg/500mg tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Glytac-M 80mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Glytac-M 80mg/500mg Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect is preventable by avoiding use in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glytac-M 80mg/500mg Tablets and seek immediate medical attention.
Long-term Glytac-M 80mg/500mg Tablet use can lead to vitamin B12 deficiency by interfering with its stomach absorption. This deficiency, if left untreated, may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glytac-M 80mg/500mg Tablets are contraindicated in patients with allergies to any ingredient or excipient. They should also be avoided in those with moderate to severe kidney disease or metabolic acidosis, such as diabetic ketoacidosis.
Combining Glytac-M 80mg/500mg tablets and alcohol is unsafe. This combination can dangerously lower blood sugar and raise the risk of lactic acidosis.
Glytac-M 80mg/500mg Table...
33
MRP 40
17% off